name: TITANIUM DIOXIDE 41 mg in 1 mL / ZINC OXIDE 115 mg in 1 mL TOPICAL CREAM [DR.JART EVERY SUN DAY MINERAL SUN SCREEN]


name: TITANIUM DIOXIDE 780 mg in 118 mL / ZINC OXIDE 900 mg in 118 mL TOPICAL LOTION [Natural SPF 50]


name: ZINC OXIDE 29 mg in 1 mL / TITANIUM DIOXIDE 19 mg in 1 mL TOPICAL CREAM [DR.JART CICAPAIR TIGER GRASS CAMO DROPS]


name: AVOBENZONE 20 mg in 1 mL / HOMOSALATE 90 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL LIQUID [MILANI MAKE IT LAST SUNSCREEN SETTING SPF 30]


name: AVOBENZONE 27 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Walgreens SPF 50 Clear Complexion Face Sunscreen]


name: AVOBENZONE 300 mg in 10 mL / HOMOSALATE 1000 mg in 10 mL / OCTISALATE 500 mg in 10 mL / OCTOCRYLENE 1000 mg in 10 mL TOPICAL SPRAY [Walgreens SPF 55 Sheer Face Mist Sunscreen]


name: Zinc Oxide 10 mg in 100 mL TOPICAL LOTION [PORESCREEN SPF40]


name: TITANIUM DIOXIDE 0.065 g in 10 mL TOPICAL LIQUID [bareMinerals Complexion Rescue Brightening Concealer SPF 25 Deep Chestnut]


name: {10 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {11 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {12 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {13 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {14 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {15 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {16 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {17 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {18 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {19 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {20 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {21 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {22 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {23 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {24 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {25 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {26 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {27 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {28 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {29 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {30 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {31 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {32 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {33 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {34 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {35 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {36 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {37 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {38 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {39 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {40 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {41 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {42 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {43 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {44 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {45 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {46 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {47 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {48 (10 ML etranacogene dezaparvovec-drlb 10000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: CATHETER,EXTERNAL EXO-CATH LG M#DYND23406


name: CATHETER,FOLEY 2-WAY HYDROGEL COUDE 16FR 5ML CARDINAL #1616C


name: RESPIRATORY FLEX TUBING SMITHS MEDICAL #002837


name: {35 (futibatinib 4 MG Oral Tablet) } Pack


name: {28 (futibatinib 4 MG Oral Tablet) } Pack


name: {21 (futibatinib 4 MG Oral Tablet) } Pack


name: BRIEF,DISCREET UNDERWEAR MEN SMALL/MEDIUM ATTENDS


name: TRACH,FILTER HEAT AND MOISTURE EXCHANGER MEDLINE #DYNJAAHME5


name: SPONGE,DRAIN 4IN X 4IN 6-PLY NON-WOVEN DYNAREX #35050


name: TRACHEAL SUCTION SET 14FR SMITHS #Z116N-14


name: CATHERIZATION SET,INTERMITTENT 16FR C#28485


name: Powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL CREAM [Lancome Paris UV Expert Aquagel Defense 50 Plus Sunscreen Broad Spectrum SPF 50 Plus Primer and Moisturizer with Antioxidant Vitamin E]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [TOO FACED HANGOVER GOOD TO GO SPF 25 BROAD SPECTRUM MOISTURIZER]


name: OCTINOXATE 67 mg in 1 mL / TITANIUM DIOXIDE 115 mg in 1 mL TOPICAL LIQUID [Lancome Paris Teint Idole Ultra Wear Breathable Coverage Foundation Reno Broad Spectrum SPF 25 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 35 mg in 1 mL / TITANIUM DIOXIDE 17 mg in 1 mL TOPICAL CREAM [REPAIRWEAR UPLIFTING FIRMING BROAD SPECTRUM SPF 15 DRY]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 44 mg in 1 mL / TITANIUM DIOXIDE 35 mg in 1 mL / ZINC OXIDE 22 mg in 1 mL TOPICAL CREAM [AGE DEFENSE BB BROAD SPECTRUM SPF 30 ALL SKIN TYPES]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 29 mg in 1 mL TOPICAL LIQUID [TOM FORD SOLEIL GLOW TINTED MOISTURIZER BROAD SPECTRUM SPF 15]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 25 mg in 1 mL TOPICAL CREAM [REDNESS solutions DAILY PROTECTIVE BASE BROAD SPECTRUM SPF 15]


name: TITANIUM DIOXIDE 73 mg in 1 mL / ZINC OXIDE 69 mg in 1 mL TOPICAL CREAM [CITY BLOCK SHEER Oil FREE DAILY FACE PROTECTOR BROAD SPECTRUM SPF 25]


name: DEXTROMETHORPHAN HYDROBROMIDE 10 mg in 5 mL / GUAIFENESIN 100 mg in 5 mL / PHENYLEPHRINE HYDROCHLORIDE 5 mg in 5 mL NOT APPLICABLE SYRUP [Dimacol]


name: OCTINOXATE 59 mg in 1 mL / TITANIUM DIOXIDE 37 mg in 1 mL / ZINC OXIDE 29 mg in 1 mL TOPICAL LOTION [REDNESS solutions MAKEUP BROAD SPECTRUM SPF 15 WITH PROBIOTIC TECHNOLOGY]


name: OCTINOXATE 60 mg in 1 mL / TITANIUM DIOXIDE 38 mg in 1 mL / ZINC OXIDE 30 mg in 1 mL TOPICAL LOTION [EVEN BETTER GLOW LIGHT REFLECTING MAKEUP BROAD SPECTRUM SPF 15]


name: OCTINOXATE 75 mg in 1 mL / OCTISALATE 45 mg in 1 mL / TITANIUM DIOXIDE 46 mg in 1 mL / ZINC OXIDE 50 mg in 1 mL TOPICAL CREAM [Clinique Broad Spectrum SPF 30 Oil Free Face With Solar Smart]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 20 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTOCRYLENE 15 mg in 1 mL TOPICAL LOTION [CVS Health SPF 50]


name: TITANIUM DIOXIDE 63 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [PEP-STAR DAILY UV PROTECTOR BROAD SPECTRUM SPF 50]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Big Lots Soundbody SPF 30 Ultra Sport Sunscreen]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [CVS Health SPORT SPF 30]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Equaline SPORT Sunscreen SPF 30]


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [TopCare Everyday SPORT Sun Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL / OXYBENZONE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE BROAD SPECTRUM SPF 50 SUNSCREEN BODY WITH SOLAR SMART]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE FOR MEN SUPER ENGERGIZER ANTI -FATIGUE HYDRATING Concentrate BROAD SPECTRUM SPF 25]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE SMART CUSTOM REPAIR MOISTURIZER BROAD SPECTRUM SPF 15 - VERY DRY/DRY]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Big Lots Soundbody SPF 50 Ultra Sport Sunscreen]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Equaline Sport Sunscreen SPF 50]


name: HOMOSALATE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [TopCare Everyday Sport Sun SPF 50]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [Kroger Sport Sunscreen Broad Spectrum SPF 15]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios Kids Gentle Broad Spectrum SPF 50 Sunscreen for Face and Body Water Resistant 80 Minutes]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Kiehls Since 1851 Dermatologist Solutions Super Fluid Daily UV Defense Broad Spectrum SPF 50 plus Sunscreen Antipollution Lightweight Formula]


name: Avobenzone 30 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 70 mg in 1 mL TOPICAL LIQUID [Maybelline New York Fit Me Matte Plus Poreless Mattifying Poreless Primer Broad Spectrum SPF 20 Sunscreen]


name: TITANIUM DIOXIDE 9.95 g in 100 mL / ZINC OXIDE 7 g in 100 mL TOPICAL CREAM [PURLISSE AGELESS GLOW BB SPF 40]


name: ZINC OXIDE 9.3 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL CREAM [Prevention Daily Matte Moisturizer SPF 30]


name: AVOBENZONE 3 g in 100 mL / OCTISALATE 4.7 g in 100 mL / OCTOCRYLENE 8.4 g in 100 mL TOPICAL LOTION [Nivea Men Maximum Hydration Face]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [CVS Health SPF 50 Ultra Protection]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Ultra Protection]


name: ZINC OXIDE 15.52 g in 50 mL TOPICAL CREAM [ISA KNOX ANEW SOLAIRE EVERYDAY MINERAL FACE PROTECTION BROAD SPECTRUM SPF 50 SUNSCREEN]


name: ZINC OXIDE 150 mg in 1 mL TOPICAL LOTION [Sqween 100% Mineral Sunscreen Broad Spectrum SPF 30 Water Resistant]


name: ZINC OXIDE 17.8 g in 100 mL TOPICAL LOTION [Fieldtrip - Whatever the Weather Daily Moisturizer Zinc Oxide Sunscreen - SPF 30]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 90 mg in 1 mL TOPICAL LOTION [Fair Light Tinted Drops]


name: TITANIUM DIOXIDE 0.747 mg in 1 mL TOPICAL LIQUID [bareMinerals ORIGINAL Liquid Mineral Foundation Broad Spectrum SPF 20 Sunscreen DEEPEST DEEP 30]


name: TITANIUM DIOXIDE 3.9 g in 100 mL / ZINC OXIDE 3.2 g in 100 mL TOPICAL LOTION [Jack Black Dual Defense Face Moisturizer - SPF 30]


name: TITANIUM DIOXIDE 65 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL LOTION [Tinted Body Screen Medium Bronze]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL AEROSOL, SPRAY [WALGREENS SPF 100 SHEER BODY SUNSCREEN MIST]


name: TITANIUM DIOXIDE 35 mg in 1 g / ZINC OXIDE 72.5 mg in 1 g TOPICAL SPRAY [TopCare Everyday Mineral Sunscreen Continuous Broad Spectrum SPF 50 Reef-Conscious Formula]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL AEROSOL, SPRAY [CVS HEALTH SPORT SPF 50 CLEAR SUNSCREEN]


name: AVOBENZONE 2 mg in 100 mL / OCTOCRYLENE 2 mg in 100 mL / OCTISALATE 4 mg in 100 mL / HOMOSALATE 4 mg in 100 mL TOPICAL LOTION [ROC MULTI CORREXION EVEN TONE LIFT DAILY MOISTURIZER SPF30]


name: HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 8 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION


name: HOMOSALATE 50 mg in 1 mL / ZINC OXIDE 30 mg in 1 mL TOPICAL LOTION [All Day Moisture]


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL LOTION [Vivier Sheer SPF 30 Mineral Tinted]


name: TITANIUM DIOXIDE 4 g in 100 g / ZINC OXIDE 19.5 g in 100 g TOPICAL AEROSOL [Hawaiian Blend Essential Zinc SPF 30]


name: TITANIUM DIOXIDE 4 g in 100 g / ZINC OXIDE 19.5 g in 100 g TOPICAL AEROSOL [Hawaiian Blend Extreme Zinc SPF 50]


name: ZINC OXIDE 80 mg in 1 mL / TITANIUM DIOXIDE 100 mg in 1 mL TOPICAL LOTION [Vivier Sheer SPF 30 Mineral]


name: ZINC OXIDE 99 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Vivier Sheer SPF 45]


name: ALLANTOIN 10 mg in 1 mL TOPICAL GEL [Macoma Senior Premium Cleanser]


name: FEEDING BAG W/PUMP SET INFINITY #INF0500-E


name: TUBE FEEDING SET,EXTENSION BOLUS AMT #6-1211


name: DRESSING,FOAM SILICONE 4IN X 4IN KENDALL #FM44


name: TRACH TUBE,SZ 10 CUFFED SMITH #101815100


name: VALVE,ENFIT,LOPEZ ENTERAL,ICU MEDICAL #9000-SEF


name: CATHERIZATION SET,FOLEY 18FR BARD #899918


name: CATHETER,SELF-CATH PLUS 12FR COLOPLAST #4812


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 30 mg in 1 mL / OCTOCRYLENE 27 mg in 1 mL TOPICAL CREAM [VITAZING SPF 15 ENERGY BOOSTING MOISTURIZER WITH MANGOSTEEN BROAD SPECTRUM SPF 15]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Men]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sem perfume]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sport Men]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sport Unissex]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Sport Women]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Teen Boy]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Teen Girl]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Unissex]


name: ALUMINUM SESQUICHLOROHYDRATE 25 g in 100 mL TOPICAL AEROSOL, SPRAY [MyHealth Mood Care Women]


name: ZINC OXIDE 15.6 g in 100 g TOPICAL CREAM [Prevention Sun Serum SPF 30 Tinted]


name: {4 (lenacapavir 300 MG Oral Tablet) } Pack


name: {4 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 4-Tablet Pack]


name: {5 (lenacapavir 300 MG Oral Tablet) } Pack


name: {5 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 5-Tablet Pack]


name: {2 (1.5 ML lenacapavir 309 MG/ML Injection) } Pack


name: {2 (1.5 ML lenacapavir 309 MG/ML Injection [Sunlenca]) } Pack [Sunlenca 927 MG Kit]


name: AVOBENZONE 2.5 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g TOPICAL CREAM [Prevention Clear Solar Gel SPF30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 10 mg in 1 mL TOPICAL SPRAY [Sunscreen]


name: ZINC OXIDE 15.6 g in 100 g TOPICAL CREAM [Prevention Sun Serum SPF30]


name: SENNOSIDES 15 kg in 15 kg POWDER [Calcium Sennosides 60%]


name: {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack


name: {1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) } Pack


name: {2 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) } Pack


name: {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension) / 1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) } Pack


name: {2 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) } Pack


name: {1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension) / 1 (sodium phenylbutyrate 3670 MG Granules for Oral Suspension) } Pack


name: OCTINOXATE 50 mg in 1 mL / TITANIUM DIOXIDE 31 mg in 1 mL / ZINC OXIDE 22 mg in 1 mL TOPICAL EMULSION [BORN THIS WAY HEALTHY GLOW SPF30]


name: TITANIUM DIOXIDE 63 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL LOTION [CLINIQUE SPF 50 BROAD SPECTRUM MINERAL SUNSCREEN FLUID FOR FACE]


name: {1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.33 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) / 1 (diphenhydramine hydrochloride 0.833 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) } Pack


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [Emme Diane Tinted Mineral Sunscreen]


name: OXIBENDAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER [OXIBENDAZOLE]


name: Ronidazole 1 kg in 1 kg NOT APPLICABLE POWDER


name: ALUMINUM CHLOROHYDRATE 20 g in 100 g TOPICAL AEROSOL, SPRAY


name: AVOBENZONE 2.5 g in 100 g / OCTISALATE 2.15 g in 100 g / HOMOSALATE 3.5 g in 100 g / OCTOCRYLENE 5.0 g in 100 g TOPICAL STICK [Refreshing Water Hydration Stick SPF 50]


name: ZINC OXIDE 13.63 g in 100 g TOPICAL STICK [Mineral Sunscreen Stick SPF 50 Fragrance-Free]


name: ZINC OXIDE 17.9 g in 100 g TOPICAL STICK [Bare Republic Mineral SPF 50]


name: OCTOCRYLENE 9.5 g in 100 mL / AVOBENZONE 2.8 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL LOTION [Vacation SPF 50 Classic]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Emzahh 28 Day]


name: HOMOSALATE 8.8 g in 100 mL / AVOBENZONE 2.9 g in 100 mL / OCTOCRYLENE 8.6 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL SPRAY [Vacation SPF 50 Classic]


name: LEUCINE 0.0025 g in 5 mL / ISOLEUCINE 0.0025 g in 5 mL TOPICAL LIQUID [ExoSCRT Derma Signal SRLV Vial 2. Diluent]


name: ZINC OXIDE 17 g in 100 g TOPICAL LOTION [LESS EVERY TONE SPF 30]


name: ZINC OXIDE 94 mg in 1 mL TOPICAL CREAM [Curology Everyday Sunscreen Broad Spectrum SPF 30 No-clog UV defense]


name: Aluminum Sesquichlorohydrate 0.15 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant Underarm Coconut Vanilla Scent]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Smooth Even Glow Tinted Mineral Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 0.21 g in 1 g / TITANIUM DIOXIDE 0.06 g in 1 g TOPICAL POWDER [Brush on Block Mineral Powder Sunscreen Translucent]


name: ZINC OXIDE 20.5 g in 100 g TOPICAL LOTION [TRADER JOES ZINC OXIDE SUNSCREEN SPF 40]


name: GUANABENZ ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: diphenhydramine / hydrocortisone / pramoxine


name: HOMOSALATE 9.8 mg in 100 mL / OCTISALATE 4.9 mg in 100 mL / AVOBENZONE 2.9 mg in 100 mL / OCTOCRYLENE 9.5 mg in 100 mL TOPICAL SPRAY [Glow Baby Brightening Setting Mist SPF 45]


name: ZINC OXIDE 10 g in 100 g TOPICAL STICK [Attitude Oceanly Phyto-Sun Tinted - SPF 15 - Broad Spectrum Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [CVS Health Sport SPF 70 Clear]


name: ISOFLUPREDONE ACETATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: Idoxuridine 1 kg in 1 kg NOT APPLICABLE POWDER


name: Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service


name: Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service


name: Cranial electrotherapy stimulation (ces) system supplies and accessories, per month


name: Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment


name: Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)


name: Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system


name: Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller


name: Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (e.g., subfacial) drug-delivery device(s)


name: Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)


name: Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)


name: Open biopsy or excision of deep cervical node(s) with intraoperative identification (e.g., mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed


name: Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance


name: Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance


name: Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance


name: Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance


name: Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed


name: Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress


name: Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation


name: Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)


name: Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)


name: Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)


name: Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)


name: Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation


name: Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation


name: Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation


name: Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with fluorescent imaging agent


name: Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel


name: Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed


name: Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent


name: Thyroidectomy, total or complete with parathyroid autotransplantation


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service


name: Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)


name: Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed


name: Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study


name: Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study


name: Adjunctive, non-implanted continuous glucose monitor or receiver


name: Non-adjunctive, non-implanted continuous glucose monitor or receiver


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 16-30 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)


name: Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)


name: Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)


name: Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)


name: Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)


name: Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)


name: Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system


name: Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system


name: The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)


name: Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist, clinical social worker, mental health counselor, or marriage and family therapist time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)


name: Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room


name: Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)


name: Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)


name: Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis


name: Skills training and development, per diem


name: Cranial electrotherapy stimulation (ces) system, any type


name: Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist


name: Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application


name: Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply


name: External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only


name: Non-pneumatic compression controller without calibrated gradient pressure


name: Non-pneumatic sequential compression garment, full leg


name: Non-pneumatic sequential compression garment, half leg


name: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count


name: Advancing cancer care mips value pathways


name: Optimal care for kidney health mips value pathways


name: Counseling, individual, by chaplain services


name: Services performed by a doula birth worker, per 15 minutes


name: Services performed by a doula birth worker, per diem


name: Financial management, self-directed, waiver; per diem


name: Supports brokerage, self-directed, waiver; per diem


name: Contact lens, hydrophilic, dual focus, per lens


name: Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary


name: Temporary Codes Assigned to DME Regional Carriers - Self-administered test


name: Washoe Tribe of Nevada and California, Tribal Entity


name: Chilkoot Indian Association, Tribal Entity


name: Louden Tribe (previously listed as Galena Village (aka Louden Village))


name: Biloxi-Chitimacha Confederation of Muskogee


name: Native Village of Nanwalek, Tribal Entity


name: Edisto Natchez Kusso Tribe of South Carolina


name: Native Village of Marshall, Tribal Entity


name: Pribilof Islands Aleut Communities of St. Paul and St. George Islands


name: Paiute Indian Tribe of Utah, Tribal Entity


name: San Manuel Band of Mission Indians, California


name: Te-Moak Tribe of Western Shoshone Indians of Nevada, Tribal Entity


name: Wampanoag Tribe of Gay Head, Tribal Entity


name: abacavir, lamivudine, and zidovudine drug combination


name: Diversity, Equity, Inclusion, and Belonging


name: Diversity, Equality, Inclusion, and Accessibility


name: Death Valley Timbisha Shoshone Band of California


name: Arapaho Tribe of the Wind River Reservation, Wyoming


name: Lumbee TribeLumbee Tribe of North Carolina


name: Mackinac Bands of Chippewa and Ottawa Indians


name: Bayou Lafourche Band of Biloxi-Chitimacha Confederation of Muskogees


name: Nulhegan Band of the Coosuk Abenaki Nation


name: Paucatuck Eastern Pequot Indians of Connecticut


name: Pee Dee Indian Nation of Upper South Carolina


name: Piscataway Indian Nation and Tayac Territory


name: Pit River Tribe, California, Tribal Entity


name: Swan Creek Black River Confederated Ojibwa Tribes of Michigan


name: Ute Mountain Tribe of the Ute Mountain Reservation, Colorado, New Mexico and Utah


name: Prenatal visits for this pregnancy:Find:Pt:^Patient:Ord


name: Cardiac device monitoring report:Find:Pt:Heart:Doc


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal:-:RptPeriod:^Patient:-:CMS Assessment


name: Health informatics leader and champion of semantic interoperability


name: Health informatics leader and champion of semantic interoperability:Hx:Pt:^Patient:Nar


name: Semen & urine analysis fertility panel:-:Pt:XXX:-


name: Portable medical order completion information


name: Portable medical order completion information:-:-:^Patient:-:POLST


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Health informatics pioneer and cofounder of LOINC


name: Health informatics pioneer and cofounder of LOINC:Hx:Pt:^Patient:Nar


name: Change in mental status:Find:Pt:^Patient:Ord


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance


name: CD49d cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: CD20 cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: Organ &or tissue donation consent:Find:Pt:{Setting}:Doc:Patient


name: Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]


name: destruction of nasal turbinate (treatment)


name: occlusion of inferior vena cava (treatment)


name: occlusion of superior vena cava (treatment)


name: MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal


name: Chief technical architect and steadfast leader of LOINC


name: Chief technical architect and steadfast leader of LOINC:Hx:Pt:^Patient:Nar


name: MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal


name: Health informatics pioneer and the father of LOINC


name: Health informatics pioneer and the father of LOINC:Hx:Pt:^Patient:Nar


name: CHAMPS pediatric fall risk assessment:-:Pt:^Patient:-:CHAMPS


name: Schmid fall risk assessment:-:Pt:^Patient:-:Schmid


name: MMP1, 1-BP INS, -1607G, PROMOTER (dbSNP rs1799750)


name: DGAT1, 3-BP DEL, 629CCT (dbSNP rs782577883)


name: OBSCN, IVS24DS, G-T, +1 (dbSNP rs200849058)


name: HSD17B13, IVS6DS, 1-BP INS, A (dbSNP rs72613567)


name: TANGO2, 34-KB DEL, EX3-9DEL (dbSNP SCV000245443)


name: Pathology report.additional specified observation:Find:Pt:Specimen:Nar


name: Pathology report.additional specified observation


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel:-:Pt:Nose:-:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Nose:Ord:Non-probe.amp.tar


name: JC virus Ab Index:ACnc:Pt:Ser/Plas:Qn:IA


name: Varicella Zoster Virus DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: HIV reverse transcriptase failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: HIV 1 group M RNA genotype:Prid:Pt:Isolate:Nom:Genotyping


name: HIV protease failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: HIV integrase failed codons:Prid:Pt:Isolate:Nom:Genotyping


name: Lymphocyte T-cell & B-cell & Natural killer subsets panel:-:Pt:CSF:-


name: Blood group antigens panel:-:Pt:RBC^Father:-


name: CD52 cell expression evaluation:Find:Pt:XXX:Doc:Flow cytometry


name: B-cell CD19 & CD20 subsets panel:-:Pt:Bld:-:Flow cytometry


name: Respiratory Allergen Panel, Area 5:-:Pt:Ser:-


name: Cortisol post dose insulin IV panel:-:Pt:Ser/Plas:-


name: Somatotropin post dose insulin IV panel:-:Pt:Ser/Plas:-


name: Monkeypox virus sequencing panel:-:Pt:XXX:-:Sequencing


name: Discharge summary note:Find:Pt:{Setting}:Doc:Osteopathic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Medical aid in dying


name: History and physical note:Find:Pt:{Setting}:Doc:Integrative medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Bariatric surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Chiropody


name: History and physical note:Find:Pt:{Setting}:Doc:Chiropractic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Community health care


name: History and physical note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: History and physical note:Find:Pt:{Setting}:Doc:Surgical oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Kinesiotherapy


name: History and physical note:Find:Pt:{Setting}:Doc:Hospitalist


name: History and physical note:Find:Pt:{Setting}:Doc:Nuclear medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Diabetology


name: History and physical note:Find:Pt:{Setting}:Doc:Optometry


name: History and physical note:Find:Pt:{Setting}:Doc:Osteopathic medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Orthotics prosthetics


name: History and physical note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: History and physical note:Find:Pt:{Setting}:Doc:Sports medicine


name: History and physical note:Find:Pt:Urgent care center:Doc:{Role}


name: History and physical note:Find:Pt:{Setting}:Doc:Child and adolescent psychology


name: History and physical note:Find:Pt:{Setting}:Doc:Cardiac surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Hematology+Medical oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Neuropsychology


name: Progress note:Find:Pt:Urgent care center:Doc:{Role}


name: Consultation note:Find:Pt:Urgent care center:Doc:{Role}


name: Consultation note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: Surgical operation note:Find:Pt:{Setting}:Doc:Bariatric surgery


name: Surgical operation note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Conference note:Find:Pt:{Setting}:Doc:Critical care medicine.team


name: Conference note:Find:Pt:{Setting}:Doc:Rapid response team


name: A little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: B little e super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: C little s super little b Ag:PrThr:Pt:RBC:Ord


name: D little h super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: D little r super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: E little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: E little s super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: H little r super little s Ab:PrThr:Pt:Ser/Plas:Ord


name: H little r super B Ab:PrThr:Pt:Ser/Plas:Ord


name: H little u little t Ab:PrThr:Pt:Ser/Plas:Ord


name: I little n super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: J little o super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11:-:RptPeriod:^Patient:-:CMS Assessment


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11


name: MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set


name: National Council of State Boards of Nursing ID:ID:Pt:Provider:Nom


name: National Council of State Boards of Nursing ID


name: Thrombospondin type I domain-containing 7A Ag:PrThr:Pt:Tiss:Ord:IF


name: Sezary syndrome monitoring:Find:Pt:Bld:Doc:Flow cytometry


name: Sezary syndrome diagnosis:Find:Pt:Bld:Doc:Flow cytometry


name: Leukemia and lymphoma immunophenotyping:Find:Pt:XXX:Doc:Flow cytometry


name: Bacterial carbapenem resistance blaIMI gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaIMI+blaNMC genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-235-like gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-24+blaOXA-40 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaSIM gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Theoretical limit of detection:Num:Pt:XXX:Qn:Calculated


name: Mast cells/Cells:NFr:Pt:Bone mar:Qn:Flow cytometry


name: B-cell precursors:NFr:Pt:Bone mar:Qn:Flow cytometry


name: Glucose post XXX challenge panel:-:Pt:Ser/Plas:-


name: End of treatment letter:Find:Pt:{Setting}:Doc:Radiation oncology


name: ER super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: NAT2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NAT2 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: NAT2 gene product metabolic activity interpretation


name: Ustekinumab & Ustekinumab Ab panel:-:Pt:Ser/Plas:-


name: Ustekinumab & Ustekinumab Antibody panel


name: Monocyte subsets panel:-:Pt:Bld:-:Flow cytometry


name: Borrelia burgdorferi Ab.IgM index:ACnc:Pt:Ser+CSF:Qn


name: Mitochondria whole genome analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Chemokine (C-C motif) ligand 14:MCnc:Pt:Urine:Qn:IA


name: Soluble urokinase plasminogen activator receptor:MCnc:Pt:Ser/Plas:Qn


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel


name: Pneumocystis jirovecii DNA:ThreshNum:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: Sphincter excision plane:Anat:Pt:Colorectal cancer specimen:Nom


name: Mesocolic excision plane:Anat:Pt:Colorectal cancer specimen:Nom


name: Depth of invasion beyond muscularis propria:Len:Pt:Colorectal cancer specimen:Qn


name: Depth of invasion beyond muscularis propria


name: Inflammatory cell infiltrate:Find:Pt:Colorectal cancer specimen:Nom


name: Lymph nodes with metastasis/Lymph nodes examined:NFr:Pt:Colorectal cancer specimen:Qn


name: Lymph nodes with metastasis/Lymph nodes examined


name: Measles virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Mumps virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Herpes simplex virus 1+2 Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Varicella zoster virus Ab.IgA:ACnc:Pt:Ser/Plas:Qn:IA


name: Dengue virus NS1 Ag:ACnc:Pt:Ser/Plas:Qn:IA


name: Hepatitis E virus Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hepatitis E virus Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus Ab.IgG panel:-:Pt:Ser/Plas:-:Line blot


name: Hantavirus puumala Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus sin nombre Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus hantaan Ab.IgG:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus Ab.IgM panel:-:Pt:Ser/Plas:-:Line blot


name: Hantavirus puumala Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus sin nombre Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus hantaan Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: Hantavirus dobrava Ab.IgM:PrThr:Pt:Ser/Plas:Ord:Line blot


name: SUMO-activating enzyme subunit 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: PM-SCL-100 extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: PKD1 gene & PKD2 gene deletion+duplication:Find:Pt:Bld/Tiss:Doc:MLPA


name: Hemosiderin:PrThr:Pt:Bld/Bone mar:Ord:Prussian blue stain


name: Purkinje cell cytoplasmic type Tr Ab:PrThr:Pt:CSF:Ord:IB


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:Ser:Ord:IB


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:CSF:Ord:IB


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:CSF:Ord:IB


name: Glutamate decarboxylase 65 Ab:PrThr:Pt:Ser:Ord:IB


name: Glial nuclear type 1 Ab:PrThr:Pt:CSF:Ord:IB


name: Glial nuclear type 1 Ab:PrThr:Pt:Ser:Ord:IB


name: Mean chromosome banding resolution:Num:Pt:Bld/Tiss:Qn:Banding


name: Contactin-associated protein 2 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Contactin-associated protein 2 Ab:PrThr:Pt:CSF:Ord:IF


name: Dipeptidyl aminopeptidase-like protein 6 Ab:PrThr:Pt:CSF:Ord:IF


name: Dipeptidyl aminopeptidase-like protein 6 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Leucine-rich glioma-inactivated protein 1 Ab:PrThr:Pt:CSF:Ord:IF


name: Leucine-rich glioma-inactivated protein 1 Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Dense fine speckled 70 protein Ab:PrThr:Pt:Ser/Plas:Ord


name: Herpes virus 6 DNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:ACnc:Pt:Bld:Qn:Probe.amp.tar


name: Silica clotting time.excess phospholipid actual/Normal:RelTime:Pt:PPP:Qn


name: Silica clotting time.excess phospholipid actual/Normal


name: MDS v3.0 - RAI v1.18.11 - Identification Information:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Identification Information


name: MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision


name: MDS v3.0 - RAI v1.18.11 - Cognitive Patterns:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Cognitive Patterns


name: MDS v3.0 - RAI v1.18.11 - Mood:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Behavior:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA &or Interim


name: MDS v3.0 - RAI v1.18.11 - Bladder and Bowel:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Bladder and Bowel


name: MDS v3.0 - RAI v1.18.11 - Active Diagnoses:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Active Diagnoses


name: MDS v3.0 - RAI v1.18.11 - Health Conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Health Conditions


name: MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Swallowing &or Nutritional Status


name: MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Oral &or Dental Status


name: MDS v3.0 - RAI v1.18.11 - Skin Conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Skin Conditions


name: MDS v3.0 - RAI v1.18.11 - Medications:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Header - Special Treatments, Procedures, and Programs


name: MDS v3.0 - RAI v1.18.11 - Restraints and Alarms:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Restraints and Alarms


name: MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting


name: MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary


name: MDS v3.0 - RAI v1.18.11 - Correction Request:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Correction Request


name: MDS v3.0 - RAI v1.18.11 - Assessment Administration:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Assessment Administration


name: Pharyngeal pathogens DNA & RNA panel:-:Pt:Thrt:-:Non-probe.amp.tar


name: Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: SARS coronavirus 2 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Parainfluenza virus 1+2+3+4 RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Respiratory syncytial virus RNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Streptococcus dysgalactiae subspecies equisimilis DNA:PrThr:Pt:Thrt:Ord:Non-probe.amp.tar


name: Views 2 && Views AP + lateral:Find:Pt:Chest>Spine.thoracic && Abdomen:Doc:XR


name: Dengue virus 1+2+3+4 RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Glucose post arginine stimulation panel:-:Pt:Ser/Plas:-


name: Glucose^2H post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin post insulin stimulation panel:-:Pt:Ser/Plas:-


name: Somatotropin post insulin stimulation panel


name: 17-Hydroxyprogesterone^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: 17-Hydroxyprogesterone post corticotropin stimulation panel


name: 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: 17-Hydroxypregnenolone & 17-Hydroxyprogesterone post corticotropin stimulation panel


name: Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel:-:Pt:Ser/Plas:-


name: Cortisol & 17-Hydroxyprogesterone post corticotropin stimulation panel


name: 17-Hydroxypregnenolone^30M post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol & Cortisone panel:-:24H:Urine:-


name: MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance


name: MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal:-:RptPeriod:^Patient:-:CMS Assessment


name: Tub &or shower transfer - functional goal:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Pain assessment interview:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Pain assessment interview


name: Nutritional approaches - on admission:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Nutritional approaches - at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Participation in assessment and goal setting:-:RptPeriod:^Patient:-:CMS Assessment


name: Number of venous and arterial ulcers:Num:RptPeriod:^Patient:Qn:CMS Assessment


name: Ulcers, wounds and skin problems:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Reason referral to local contact agency not made:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Determination of pressure injury risk:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: W little r super little b Ag:PrThr:Pt:RBC:Ord


name: Treatment preferences under certain health conditions:Find:Pt:^Patient:Nar:Reported


name: Coagulation factor X inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Acute febrile illness global pathogens panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Acute febrile illness global pathogens panel


name: MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs


name: Return to Community:-:RptPeriod:^Patient:-:CMS Assessment


name: Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel:-:Pt:Bld.dot:-


name: Palmitoyl protein thioesterase & Tripeptidyl peptidase I panel


name: Jurisdiction where advance directive is accepted:Loc:Pt:^Patient:Nom


name: Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel:-:Pt:Ser/Plas:-


name: Borrelia burgdorferi Ab.IgG & IgM with reflex to immunoassay panel


name: Bacillus anthracis plasmid pXO1 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO2 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Bacillus anthracis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO1 DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Bacillus anthracis plasmid pXO2 DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Yersinia pestis DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Referral has been made to the local contact agency:Find:RptPeriod:Patient education material:Ord:CMS Assessment


name: Troponin I.cardiac^2H post baseline measurement:MCncDiff:Pt:Ser/Plas:Qn:Calculated


name: inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript:Find:Pt:Bld/Bone mar:Doc:Molgen


name: Lung cancer targeted gene fusion transcript analysis:Find:Pt:Tiss:Doc:Sequencing


name: Lung cancer targeted gene fusion transcript analysis


name: BAP1 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BAP1 gene deletion+duplication & full mutation analysis


name: FH gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: FH gene deletion+duplication & full mutation analysis


name: NF1 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: NF1 gene deletion+duplication & full mutation analysis


name: RET gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: RET gene deletion+duplication & full mutation analysis


name: HBA1 & HBA2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP1BB gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP1BA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GP9 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: PAH gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ADA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CLCN7 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Copy number variation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Monkeypox virus & Orthopoxvirus.non-variola DNA panel:-:Pt:XXX:-


name: Monkeypox virus & Orthopoxvirus.non-variola DNA panel


name: Monkeypox virus & Orthopoxvirus.non-variola DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel:-:24H:Urine:-


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel


name: Tapentadol & Nortapentadol panel:-:Pt:Urine:-


name: Phenylalanine & Tyrosine panel:-:Pt:Ser/Plas:-


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel:-:Pt:Ser/Plas:-:IA


name: Amyloid protein:Find:Pt:Tiss:Doc:Congo red stain+LC/MS/MS


name: Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel:-:Pt:Ser:-


name: C peptide post XXX challenge panel:-:Pt:Ser:-


name: Lymphocyte TCR alpha beta double negative subsets panel:-:Pt:Bld:-


name: Lymphocyte TCR alpha beta double negative subsets panel


name: Blastomyces sp & Blastomyces dermatitidis Ag panel:-:Pt:Urine:-


name: Blastomyces sp & Blastomyces dermatitidis Ag panel


name: Pediatric autoimmune central nervous system disorders evaluation panel:-:Pt:CSF:-


name: Pediatric autoimmune central nervous system disorders evaluation panel


name: Pediatric autoimmune central nervous system disorders evaluation panel:-:Pt:Ser/Plas:-


name: Microorganism level of similarity to reference sample:Score:Pt:Isolate/Specimen:Qn:MS.MALDI-TOF


name: Human coronavirus 229E RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Influenza virus A H1 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Respiratory syncytial virus B RNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Varicella zoster virus DNA:PrThr:Pt:Respiratory System Specimen:Ord:Probe.amp.tar


name: Self-Care - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Self-Care - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility - Discharge Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility - OBRA/Interim Performance:-:RptPeriod:^Patient:-:CMS Assessment


name: Intentional animal genomic alteration label:-:-:^FDA product label:Nar


name: Intentional animal genomic alteration label


name: CHAMPS pediatric fall risk assessment:Imp:Pt:^Patient:Ord:CHAMPS


name: Soluble urokinase plasminogen activator receptor:MCnc:Pt:Plas:Qn


name: Solitary lung nodule risk of malignancy:Scale:Pt:^Patient:Ord:Calculated.Nodify XL2


name: Solitary lung nodule risk of malignancy:Scale:Pt:^Patient:Ord:Calculated.Nodify CDT


name: Contactin-associated protein 1 Ab.IgG & Neurofascin155 Ab.IgG4 panel:-:Pt:Ser/Plas:-


name: Contactin-associated protein 1 Antibody.immunoglobulin G & Neurofascin155 Antibody.IgG4 panel


name: Contactin-associated protein 1 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Risk adjustment coding gap report:Find:Pt:{Setting}:Doc:{Role}


name: HBA1+2 gene FIL deletion:PrThr:Pt:Bld:Ord:Molgen


name: HBA1+2 gene THAI deletion:PrThr:Pt:Bld:Ord:Molgen


name: Alpha globin gene deletion panel:-:Pt:Bld:-


name: Adenovirus DNA & Human Metapneumovirus & Rhinovirus RNA panel:-:Pt:Respiratory System Specimen:-:Probe.amp.tar


name: Adenovirus DNA & Human Metapneumovirus & Rhinovirus RNA panel


name: Bacterial susceptibility panel:-:Pt:Bld.pos growth:-:MIC.VOC detection


name: Colony count:NCnc:Pt:XXX:Qn:Culture.standard plate count


name: Salmonella enterica serotype 1,4,[5],12:i:-:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Equine herpesvirus 1 non-neuropathogenic A2254 variant DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Equine herpesvirus 1 neuropathogenic G2254 variant DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Canine parvovirus DNA VP2 gene:PrThr:Pt:Isolate:Ord:Sequencing


name: Canine Parvovirus 2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Hemorrhagic enteritis virus Ab:Titr:Pt:Ser:SemiQn:IA


name: Hemorrhagic enteritis virus Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Hemorrhagic enteritis virus Ab/Positive control


name: Porcine deltacoronavirus S gene:Seq:Pt:Isolate:Nom:Sequencing


name: Bovine parainfluenza virus 3 Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Porcine epidemic diarrhea virus S1 gene:Prid:Pt:Isolate:Nom:Sequencing


name: Porcine epidemic diarrhea virus Ab.IgG:ACnc:Pt:XXX:Qn:IA


name: Porcine epidemic diarrhea virus S1 gene Ab.IgA:ACnc:Pt:Saliva:Qn:IA


name: Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS:NFr:Pt:Isolate:Qn:Sequencing


name: Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to RespPRRS


name: Fungal 18S rRNA gene:Prid:Pt:XXX:Nom:Sequencing


name: Fungal 18S rRNA gene:Seq:Pt:XXX:Nom:Sequencing


name: Salmonella sp whole genome:Seq:Pt:Isolate:Nom:Sequencing


name: Comprehensive plan of care note:Find:Pt:{Setting}:Doc:Multidisciplinary


name: Bacterial versus viral etiology indicator panel:-:Pt:Ser/Plas/Bld:-


name: Bacterial versus viral etiology indicator panel


name: Tumor necrosis factor ligand superfamily member 10:MCnc:Pt:Ser/Plas/Bld:Qn


name: Bacterial versus viral infection likelihood:Score:Pt:^Patient:Qn:Calculated


name: Bacterial versus viral infection likelihood


name: Hepatocyte Ag by paraffin 1:Find:Pt:Bld/Tiss:Ord:Immune stain


name: Schmid fall risk assessment:Imp:Pt:^Patient:Ord:Schmid


name: Escherichia coli enteroinvasive DNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Sapovirus genogroups I+II+IV RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Sapovirus genogroup V RNA:PrThr:Pt:Stool:Ord:Probe.amp.tar


name: Thyroglobulin & Thyroglobulin Ab panel:-:Pt:Tiss.FNA:-


name: Bacterial gyrB gene drug resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Multisection transthoracic limited for congenital disease:Find:Pt:Chest>Heart:Doc:US


name: Multisection transthoracic limited for congenital disease


name: Multisection transthoracic for congenital disease:Find:Pt:Chest>Heart:Doc:US


name: Multisection transthoracic for congenital disease


name: Views for protein-losing enteropathy^W Tc-99m HSA IV:Find:Pt:Abdomen+Pelvis>Gastrointestinal tract:Doc:NM


name: Borrelia burgdorferi Ab.IgG bands:Num:Pt:CSF:Qn:IB


name: Borrelia burgdorferi Ab.IgM bands:Num:Pt:CSF:Qn:IB


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Special treatments, procedures, and programs


name: MDS v3.0 - RAI v1.14.1 - Participation in assessment and goal setting


name: How much of the time has pain made it hard for you to sleep at night


name: How often have you limited your day-to-day activities because of pain


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over


name: Troponin I.cardiac^2H post baseline measurement


name: 17-Hydroxypregnenolone^1H post dose corticotropin


name: 17-Hydroxypregnenolone^30M post dose corticotropin


name: Views for protein-losing enteropathy^W Tc-99m HSA IV


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Pain assessment interview during assessment period


name: PRRSV RespPRRS Hmlgy | Isolate | Microbiology


name: Anaplasma phagocytophilum, Babesia microti and Ehrlichia chaffeensis IgG panel | Serum | Microbiology Panels


name: Blastomyces sp & Blastomyces dermatitidis Ag panel | Urine | Microbiology Panels


name: Amoxicillin+Clavulanate | Positive blood culture | Antibiotic susceptibilities


name: Ampicillin+Sulbactam | Positive blood culture | Antibiotic susceptibilities


name: cefTAZidime+Avibactam | Positive blood culture | Antibiotic susceptibilities


name: Ceftolozane+Tazobactam | Positive blood culture | Antibiotic susceptibilities


name: Meropenem+Vaborbactam | Positive blood culture | Antibiotic susceptibilities


name: Piperacillin+Tazobactam | Positive blood culture | Antibiotic susceptibilities


name: Trimethoprim+Sulfamethoxazole | Positive blood culture | Antibiotic susceptibilities


name: Bacterial susceptibility panel | Positive blood culture | Antibiotic Susceptibility Panels


name: 3-Methoxytyramine.free/Creatinine | Serum or Plasma | Chemistry - non-challenge


name: Metanephrine.free/Creatinine | Serum or Plasma | Chemistry - non-challenge


name: Electrolytes panel | Blood venous | Chemistry Panels


name: Gas and electrolytes panel | Blood venous | Chemistry Panels


name: Phenylalanine and Tyrosine panel | Serum or Plasma | Chemistry Panels


name: Thyroglobulin & Thyroglobulin Ab panel | Tissue FNA | Chemistry Panels


name: Glucose post arginine stimulation panel | Serum or Plasma | Challenge Bank Panels


name: Dupilumab | Serum or Plasma | Drug toxicology


name: Metanephrine, Normetanephrine, 3-Methoxytyramine panel | Urine | Drug and Toxicology Panels


name: Tapentadol and Nortapentadol panel | Urine | Drug and Toxicology Panels


name: Thrombin generation test | Platelet poor plasma | Coagulation


name: Blood group antigens panel | Father | Blood Bank Panels


name: Blood group antigens panel | Father | Red Blood Cells | Blood Bank Panels


name: CD20 cell expression evaluation | XXX | Cell markers


name: CD49d cell expression evaluation | XXX | Cell markers


name: CD52 cell expression evaluation | XXX | Cell markers


name: Leukemia and lymphoma immunophenotyping | XXX | Cell markers


name: Lymphocyte T-cell and B-cell and Natural killer subsets panel | Cerebral spinal fluid | Cellmarker Panels


name: Lymphocyte TCR alpha beta double negative subsets panel | Blood | Cellmarker Panels


name: Mitochondria whole genome analysis | Blood or Tissue | Molecular pathology


name: Preimplantation multigene analysis | Embryo | Molecular pathology


name: Lung cancer targeted gene fusion transcript analysis | Tissue and Smears | Molecular pathology


name: NAT2 gene product metabolic activity interpretation | Blood or Tissue | Pharmacogenomics


name: Copy number variation analysis | Blood or Tissue | Molecular pathology


name: Alpha globin gene deletion panel | Blood | Molecular Pathology Panels


name: Inflammatory cell infiltrate | Colorectal cancer specimen | Pathology


name: Depth of invasion beyond muscularis propria | Colorectal cancer specimen | Pathology


name: Mesocolic excision plane | Colorectal cancer specimen | Pathology


name: Sphincter excision plane | Colorectal cancer specimen | Pathology


name: Pathology report additional specified observation | Specimen | Pathology


name: Pathologic casts | Urine sediment | Urinalysis


name: Consultation note | Urgent care center | Document ontology


name: History and physical note | Urgent care center | Document ontology


name: Admission evaluation note | Telehealth | Document ontology


name: Progress note | Urgent care center | Document ontology


name: Discharge summary note | Ambulance | Document ontology


name: Appointment reminder | {Setting} | Document ontology


name: Organ AndOr tissue donation consent | {Setting} | Document ontology


name: Cardiac output | Heart.ventricle Right | Specific hemodynamics


name: Application of transcutaneous electric nerve stimulator


name: Discharge to another facility/institution


name: Anticoagulant (e.g., warfarin, heparin, or low-molecular weight heparin)


name: 17-Hydroxyprogesterone^1H post dose corticotropin|Pt|Ser/Plas


name: 17-Hydroxyprogesterone^30M post dose corticotropin|Pt|Ser/Plas


name: GUAIFENESIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [TopCare Everyday Sport Continuous Broad Spectrum SPF 70]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Ultra Sheer]


name: HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Wegmans Sheer Broad Spectrum SPF 30 Dry Touch Sunscreen]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Walgreens SPF 50 Hydrating]


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Wegmans Kids and Sport Broad Spectrum SPF 50 Sunscreen]


name: Zinc Oxide 160 mg in 1 g TOPICAL CREAM [Emme Diane Pure Protection Tinted Antioxidant Sunscreen]


name: .ALPHA.-HEXYLCINNAMALDEHYDE 0.00244785 g in 100 mL / LIMONENE, (+)- 0.001156785 g in 100 mL TOPICAL CREAM [Puritying Skin BalanceCream]


name: .BETA.-CITRONELLOL, (R)- 0.00271206 g in 100 mL TOPICAL LIQUID [Hydrating extra concentrate serum]


name: .BETA.-CITRONELLOL, (R)- 0.0090402 g in 100 mL TOPICAL LIQUID [Hydrating Treatment Toner]


name: .BETA.-CITRONELLOL, (R)- 0.0090408 g in 100 mL / GERANIOL 0.003019675 g in 100 mL TOPICAL OIL [Hydrating luxurious roseoil]


name: .BETA.-CITRONELLOL, (R)- 0.0090408 g in 100 mL TOPICAL LIQUID [Purifying relief soothing gel essence]


name: ADENOSINE 0.04 g in 100 mL / NIACINAMIDE 2 g in 100 mL TOPICAL LIQUID [Hydrating all in one concentrate treatment mask]


name: LIMONENE, (+)- 0.00185573 g in 100 mL TOPICAL LIQUID [Purifying Balance Soothing Peeling Pad]


name: LIMONENE, (+)- 0.00371146 g in 100 g / LINALOOL, (+/-)- 0.00109203 g in 100 g TOPICAL LIQUID [Purifying centella soothing mask]


name: STARFIRE RED PRISTELLA TRANSGENIC WHOLE (RPM2022 RDNA CONSTRUCT) 1 [Amb'a'1'U] in 1 [Amb'a'1'U] NOT APPLICABLE NOT APPLICABLE [StarFire Red Pristella]


name: ATIPAMEZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [Bliss Block Star Sheer Liquid Daily Sunscreen SPF 50 SPF-50]


name: CAPSAICIN 0.2 g in 100 g TOPICAL CLOTH [Nufabrx Arm Sleeve]


name: LINALOOL, (+/-)- 0.0028142856 g in 100 g / .BETA.-CITRONELLOL, (R)- 0.03018988 g in 100 g / GERANIOL 0.007430248 g in 100 g TOPICAL POWDER [Protecting may morning cushion 21 (refill)]


name: Maropitant Citrate 1 kg in 1 kg NOT APPLICABLE POWDER


name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL CREAM [Protecting base suncream]


name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL CREAM [Protecting tone up and glow B.B]


name: CAPSAICIN 0.15 g in 100 g TOPICAL CLOTH [Nufabrx Knee Sleeve]


name: CAPSAICIN 0.12 g in 100 g TOPICAL CLOTH [Nufabrx Foot/Ankle Sleeve]


name: RICE GERM 0.0000001 g in 100 mL TOPICAL LIQUID [Claritying rice rebalancing cleansing water]


name: ZINC OXIDE 19.6 g in 100 mL TOPICAL LOTION [Oars and Alps SPF 50 Mineral]


name: AVOBENZONE 2.9 g in 100 mL / HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL SPRAY [Oars and Alps SPF 70 Hydrating Antioxidant Sunscreen]


name: ZINC OXIDE 15.7 g in 100 mL / TITANIUM DIOXIDE 3.4 g in 100 mL TOPICAL SPRAY [Oars and Alps SPF 50 100% Mineral Antioxidant Sunscreen]


name: HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL LOTION [Coppertone Complete Sunscreen SPF 45]


name: RICE GERM 0.00055 g in 100 mL TOPICAL LIQUID [Claritying rice gently off lip and eye remover]


name: LINALOOL, (+/-)- 0.0123856248 g in 100 mL / .BETA.-CITRONELLOL, (R)- 0.0072288108 g in 100 mL / GERANIOL 0.003659868 g in 100 mL / LIMONENE, (+/-)- 0.0330317226 g in 100 mL TOPICAL CREAM [Intensive treatment bodycream for mommy to be and all skin]


name: Johnson and Johnson First Aid Travel Ready 80 CT KIT


name: Johnson and Johnson First Aid All Purpose 160 CT KIT


name: ZINC OXIDE 24 g in 100 g TOPICAL LOTION [Eucerin Sensitive Mineral Face Sunscreen SPF 35]


name: MINOCYCLINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [Hydrating all in one glow concentrate ampoule]


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 9 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Coppertone Every Tone Sunscreen SPF 50]


name: HOMOSALATE 0.1015 g in 1 g / OCTINOXATE 0.077 g in 1 g / ZINC OXIDE 0.077 g in 1 g TOPICAL CREAM


name: OCTISALATE 5 g in 100 g / OCTOCRYLENE 10 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g TOPICAL LOTION [Coppertone Oil Free and Shine Control Face Sunscreen SPF 45]


name: OCTISALATE 5 mg in 100 mg / HOMOSALATE 10 mg in 100 mg / AVOBENZONE 3 mg in 100 mg / OCTOCRYLENE 10 mg in 100 mg TOPICAL GEL [Sunscreen]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [GUARDIAN ANGEL SUPER PEPTIDE SUNSCREEN MILK SPF-50]


name: ZINC OXIDE 24.08 g in 100 g SUPRACHOROIDAL LOTION [Coppertone Kids Roll-On Sunscreen SPF 50]


name: LIMONENE, (+)- 0.005016382 g in 100 mL TOPICAL GEL [Purifying S.O.S spotgel]


name: ZINC OXIDE 19 g in 100 g TOPICAL CREAM [Wonderscreen Tinted Broad Spectrum SPF 30]


name: AVOBENZONE 100 mg in 4 g / OCTINOXATE 196 mg in 4 g / OCTOCRYLENE 120 mg in 4 g TOPICAL EMULSION [cle de peau BEAUTE PROTECTIVE LIP TREATMENT SPF 25]


name: METFORMIN HYDROCHLORIDE 500 mg in 1 kg NOT APPLICABLE POWDER


name: METFORMIN HYDROCHLORIDE 750 mg in 1 kg NOT APPLICABLE POWDER


name: METFORMIN HYDROCHLORIDE 97 mg in 100 mg POWDER


name: POTASSIUM CHLORIDE 50 kg in 50 kg NOT APPLICABLE POWDER


name: OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [CVS Health Sport SPF 50 Sunscreen]


name: ZINC OXIDE 15.2 g in 100 mL TOPICAL AEROSOL, SPRAY [Chantecaille SeaScreen 30 Mineral Broad-Spectrum Sunscreen Mist SPF 30]


name: ZINC OXIDE 180 mg in 1 mL TOPICAL SOLUTION [SEAWEED BATH CO. Super Sheer Face Serum SPF-50]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Delicate Rose Invisible]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 5 g in 100 mL / OCTISALATE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [CVS Health SPF 50 Clear]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [H-E-B SOLUTIONS SUNSCREEN COCONUT SPF 50 CONTINUOUS]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Market Basket Continuous Sunscreen SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Wegmans Sport and Kids Clear Continuous Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Equate Sunscreen for All Skin Tones SPF 50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [TopCare Everyday Ultra Protection Sun SPF 30]


name: HOMOSALATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / AVOBENZONE 25 mg in 1 mL TOPICAL LOTION [CVS Health SPF 30 Breakout Free Face]


name: OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [CVS Health SPF 30 Clear]


name: OCTOCRYLENE 35 mg in 1 mL / OCTISALATE 50 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / AVOBENZONE 27 mg in 1 mL TOPICAL LOTION [Walgreens SPF 30 Hydrating]


name: PETROLATUM 1.147 g in 3.7 g / OCTINOXATE 0.2775 g in 3.7 g / OXYBENZONE 0.111 g in 3.7 g / AVOBENZONE 0.074 g in 3.7 g TOPICAL LIPSTICK [ELIZABETH ARDEN EIGHT HR PROTECTANT CLEAR]


name: TITANIUM DIOXIDE 3.71 g in 100 mL / ZINC OXIDE 2.71 g in 100 mL TOPICAL CREAM [spf 30 mineral Sunscreen]


name: Zinc Oxide 126 mg in 1 mL TOPICAL LOTION [SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen 13 La Cienega]


name: Zinc Oxide 126 mg in 1 mL TOPICAL LOTION [SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen 18 Montana]


name: Zinc Oxide 126 mg in 1 mL TOPICAL LOTION [SunnyDays Broad Spectrum SPF 30 Tinted Sunscreen 38 Pomona]


name: Butylscopolamine Bromide 1 kg in 1 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 20.8 g in 100 mL TOPICAL LIQUID [Kind Tint SPF 30]


name: ZINC OXIDE 20.8 g in 100 mL TOPICAL SPRAY [Glow Baby Super Lit SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Secret Outlast Completely Clean Invisible Completely Clean]


name: AVOBENZONE 0.1175 g in 4.25 g / OCTINOXATE 0.282 g in 4.25 g / OXYBENZONE 0.141 g in 4.25 g TOPICAL STICK [Sun Shades Lip Balm Cranberry Tangerine]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 15 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 70]


name: OCTOCRYLENE 10 g in 100 mL / AVOBENZONE 2 g in 100 mL / HOMOSALATE 5 g in 100 mL / OCTISALATE 2 g in 100 mL TOPICAL LOTION [Premium Moisturizing Sunscreen Broad Spectrum SPF 15]


name: TITANIUM DIOXIDE 172.9 mg in 1 g / ZINC OXIDE 200 mg in 1 g TOPICAL POWDER [Derma E Mineral sunscreen Mineral]


name: TITANIUM DIOXIDE 35 mg in 1 g / ZINC OXIDE 72.5 mg in 1 g TOPICAL SPRAY [Fruit of the Earth Sun Town City Baby and Kids Mineral SPF 50 Sunscreen]


name: ZINC OXIDE 20 g in 100 mL TOPICAL LOTION [SOLARA SUNCARE - FORTUNE TELLER SPF-30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Invigorating Citrus Invisible]


name: OCTOCRYLENE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 15 g in 100 mL TOPICAL LOTION [Vegan Collagen Every Day SPF 30]


name: TITANIUM DIOXIDE 30 mg in 1 mL / ZINC OXIDE 100 mg in 1 mL TOPICAL LOTION [Fruit of the Earth Sun Town City Mineral SPF 30 Sunscreen]


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [Priia Tinted Mineral Sunscreen and Primer]


name: ZINC OXIDE 150 mg in 1 g TOPICAL SPRAY [Fruit of the Earth Sun Town City Mineral SPF 30 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cabana Beach Club with Blood Orange and Essential Oils SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cabana Beach Club with Manuka Honey and Essential Oils SPF 50 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cabana Beach Club with Mentha and Essential Oils SPF 50 Sunscreen]


name: OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 7 g in 100 g / HOMOSALATE 8 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL AEROSOL, SPRAY [Coppertone Limited Edition Sunscreen SPF 30]


name: AVOBENZONE 3 g in 30 mL / OCTISALATE 5 g in 30 mL TOPICAL LOTION [TULA RADIANT SKIN BRIGHTENING SERUM SKIN TINT SUNSCREEN BROAD SPECTRUM SPF 30]


name: AVOBENZONE 1.031 g in 50 mL / OCTINOXATE 2.52595 g in 50 mL / OCTOCRYLENE 2.5775 g in 50 mL / OXYBENZONE 1.031 g in 50 mL TOPICAL CREAM [cle de peau BEAUTE PROTECTIVE FORTIFYING n]